4 Strong Value Stocks in the US Market
The goal of value investing is to find a balance point where a company's stock price is reasonable, but its business operations are strong and viable. A good value stock can be recognized by a sober price-to-earnings (P/E) ratio and stable growth prospects, while avoiding value traps where a low price hides deep structural problems. We have reached the beginning of April 2026, which means the upcoming first-quarter earnings season will bring new clarity to companies' performance. In the meantime, we highlight four US market companies that offer attractive valuations and have shown convincing operating profit growth in their latest reports.
Cincinnati Financial's valuation level is attractive considering its fundamentals, offering a P/E ratio of 11.2. This indicates a reasonable value for the stock, especially considering the company's impressive operating profit growth in the last quarter, which accelerated to 75.4%. Such a combination of a low valuation multiple and strong profit growth suggests that the market has not yet fully priced in the company's recent progress.
The strong business performance is driven by higher insurance premiums and lower-than-expected catastrophe loss payouts, which have significantly improved the company's profitability. Additionally, the recently reported record quarterly profit and dividend increase reflect the company's financial stability. As a main risk, it is worth monitoring unexpected large weather-related losses, which can always pressure margins in the insurance sector, but the current strong cash flow provides the company with a solid footing.
Eversource Energy is trading at a reasonable price level, valued at a P/E ratio of 15.8. The company's fundamental strength is highlighted by an exceptionally good financial result, where operating profit made a massive 104.3% jump year-over-year. For the utilities sector, this is very rapid growth, making the current price level entirely logical for an investor evaluating the long-term perspective.
The explosive profit growth is driven by successful investments in the power grid and higher gas tariffs, which have clearly started to bear fruit. The company's strong financial position is also confirmed by the recently paid increased dividend. Although regulatory risks and interest rate changes must always be considered with utility companies, Eversource's ability to grow revenues faster than costs shows that their core business is currently very efficient.
NetApp, a provider of data storage solutions, stands out in the technology sector with a balanced P/E ratio of 16.1. Considering that the company's operating profit grew by 20.2% in the last quarter, it is a reasonably valued company in a field where many competitors trade at significantly higher multiples. This shows that the company can offer real growth without inflated expectations.
The business is driven by strong demand for cloud services and new storage devices, supported by the AI data engine recently launched in collaboration with NVIDIA. Although broader tech sector sell-offs and geopolitical tensions may cause short-term fluctuations in the stock price, NetApp's fundamental picture is strong. It offers an opportunity to follow the growth trend of artificial intelligence and cloud services through a company that keeps its costs under strict control.
Pharmaceutical giant Bristol Myers Squibb is trading at a P/E ratio of 17.4, which is an entirely reasonable value in the context of the pharmaceutical sector. What makes this number particularly noteworthy is the company's operating profit growth in the last quarter, which accelerated to a staggering 206.7%. Such a robust profit jump shows that the company has managed to significantly improve its financial metrics, offering a good balance between price and quality.
The strong result is driven by a successful cost-cutting program and the successful sales of new drugs, such as Opdivo, which recently received expanded approval. This has helped alleviate the market's earlier fears about the expiration of patents for older drugs. The main risk to monitor is the ability of new products to replace the aging portfolio, but the current stable dividend payment and clear signs of improving efficiency make it a strong company to watch as a value investor.
Conclusion
In conclusion, these four companies prove that with careful analysis, it is possible to find reasonably valued and strong businesses across very different sectors – be it insurance, utilities, technology, or the pharmaceutical industry. Their common denominator is the ability to keep costs under control and grow operating profit, which is the best defense against falling into a value trap. As we await the upcoming first-quarter results, it is worth remembering that true value lies not only in a low price but in a company's ability to generate long-term and sustainable profit.
RYTM content is for informational purposes only, not financial advice or recommendations. You are solely responsible for your investment decisions. Always consult a professional.